$HWKN
HAWKINS INC

2024 Q1 Form 10-Q Financial Statement

#000004625024000004 Filed on January 31, 2024

View on sec.gov

Income Statement

Concept 2024 Q1
Revenue $223.0M
YoY Change 1.73%
Cost Of Revenue $177.5M
YoY Change -2.97%
Gross Profit $45.51M
YoY Change 25.47%
Gross Profit Margin 20.41%
Selling, General & Admin $25.43M
YoY Change 21.06%
% of Gross Profit 55.87%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.954M
YoY Change 27.88%
% of Gross Profit 19.67%
Operating Expenses $25.43M
YoY Change 21.06%
Operating Profit $20.08M
YoY Change 31.55%
Interest Expense -$1.249M
YoY Change -19.21%
% of Operating Profit -6.22%
Other Income/Expense, Net $490.0K
YoY Change 5.38%
Pretax Income $19.33M
YoY Change 36.23%
Income Tax $5.493M
% Of Pretax Income 28.42%
Net Earnings $13.83M
YoY Change 28.87%
Net Earnings / Revenue 6.2%
Basic Earnings Per Share
Diluted Earnings Per Share $0.66
COMMON SHARES
Basic Shares Outstanding 20.95M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.153M
YoY Change 16.38%
Cash & Equivalents $7.153M
Short-Term Investments
Other Short-Term Assets $6.596M
YoY Change -6.44%
Inventory $74.60M
Prepaid Expenses
Receivables $114.5M
Other Receivables $0.00
Total Short-Term Assets $202.8M
YoY Change -15.58%
LONG-TERM ASSETS
Property, Plant & Equipment $208.9M
YoY Change 17.1%
Goodwill $103.4M
YoY Change 33.59%
Intangibles $116.6M
YoY Change 55.61%
Long-Term Investments
YoY Change
Other Assets $4.912M
YoY Change -10.63%
Total Long-Term Assets $455.1M
YoY Change 28.65%
TOTAL ASSETS
Total Short-Term Assets $202.8M
Total Long-Term Assets $455.1M
Total Assets $657.9M
YoY Change 10.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $56.39M
YoY Change 11.5%
Accrued Expenses $19.53M
YoY Change 8.46%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $9.913M
YoY Change 0.0%
Total Short-Term Liabilities $103.3M
YoY Change 21.71%
LONG-TERM LIABILITIES
Long-Term Debt $88.82M
YoY Change -26.42%
Other Long-Term Liabilities $1.310M
YoY Change -11.9%
Total Long-Term Liabilities $90.13M
YoY Change -26.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $103.3M
Total Long-Term Liabilities $90.13M
Total Liabilities $251.9M
YoY Change -0.37%
SHAREHOLDERS EQUITY
Retained Earnings $364.5M
YoY Change 24.01%
Common Stock $38.36M
YoY Change -12.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $406.0M
YoY Change
Total Liabilities & Shareholders Equity $657.9M
YoY Change 10.76%

Cashflow Statement

Concept 2024 Q1
OPERATING ACTIVITIES
Net Income $13.83M
YoY Change 28.87%
Depreciation, Depletion And Amortization $8.954M
YoY Change 27.88%
Cash From Operating Activities $41.89M
YoY Change 62.75%
INVESTING ACTIVITIES
Capital Expenditures $11.90M
YoY Change -202.27%
Acquisitions
YoY Change
Other Investing Activities -$4.221M
YoY Change -7637.5%
Cash From Investing Activities -$16.12M
YoY Change 39.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -24.35M
YoY Change 104.08%
NET CHANGE
Cash From Operating Activities 41.89M
Cash From Investing Activities -16.12M
Cash From Financing Activities -24.35M
Net Change In Cash 1.412M
YoY Change -36.45%
FREE CASH FLOW
Cash From Operating Activities $41.89M
Capital Expenditures $11.90M
Free Cash Flow $29.99M
YoY Change -19.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Liabilities
Liabilities
250293000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
240519000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
23698000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
23800000 usd
CY2023Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
11437000 usd
CY2023Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
9343000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10943000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2175000 usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20790292 shares
us-gaap Net Income Loss
NetIncomeLoss
61531000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.31
CY2023Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.47
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.42
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
14885000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
10733000 usd
us-gaap Net Income Loss
NetIncomeLoss
61531000 usd
us-gaap Net Income Loss
NetIncomeLoss
48428000 usd
CY2023Q4 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1299000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-139000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-244000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
2303000 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13586000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10594000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
61287000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
465000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
19695000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
313277000 usd
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
191861 shares
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7651000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6645000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
79678000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
90871000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
109797000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
101731000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11107000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8687000 usd
CY2023Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
3633000 usd
CY2023Q2 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
3912000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20790292 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20850454 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20850454 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
208000 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
209000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
36781000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
44443000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
354069000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
302424000 usd
CY2023Q4 us-gaap Revenues
Revenues
208496000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2696000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2940000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
393754000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
350016000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
644047000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
590535000 usd
CY2023Q1 us-gaap Revenues
Revenues
219218000 usd
us-gaap Revenues
Revenues
696142000 usd
us-gaap Revenues
Revenues
706953000 usd
CY2023Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
166248000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
182947000 usd
us-gaap Gross Profit
GrossProfit
148125000 usd
us-gaap Gross Profit
GrossProfit
129394000 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23774000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21004000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
64173000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
59727000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
18474000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
15267000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
83952000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
69667000 usd
CY2023Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1168000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1546000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3033000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3858000 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
853000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
465000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
901000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-744000 usd
CY2023Q4 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
18159000 usd
CY2023Q1 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
14186000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
81820000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
65065000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3274000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3453000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20289000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16637000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
14885000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
10733000 usd
us-gaap Net Income Loss
NetIncomeLoss
48428000 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20781632 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20818347 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20864349 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20847285 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20907321 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20974264 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21004077 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21004849 shares
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.95
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.32
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.93
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
50731000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
350016000 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2023Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3160000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
959000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2023Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2140000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1147000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
749000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
23430000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
371001000 usd
CY2023Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2023Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2023Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3375000 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1260000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2023Q4 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
9752000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
306000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
23216000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
382656000 usd
CY2023Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2023Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2023Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3351000 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1287000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1096000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1299000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
14885000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
393754000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
302601000 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2958000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
595000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2022Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1550000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
986000 usd
CY2022Q3 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
6557000 usd
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2022Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
CY2022Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2942000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1085000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2022Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
17000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1977000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
18000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
331414000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2943000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1084000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1011000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-139000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
10733000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
341160000 usd
us-gaap Net Income Loss
NetIncomeLoss
61531000 usd
us-gaap Net Income Loss
NetIncomeLoss
48428000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
22849000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20373000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1884000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1442000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
901000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-744000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3506000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2764000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
70000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
225000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-22500000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2336000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-25665000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6596000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-14334000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-16231000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-610000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3652000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1804000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1453000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1824000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1762000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
922000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
929000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
117610000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
44541000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28248000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32307000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
78855000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-723000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-352000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-106380000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31955000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
9886000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8843000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2243000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2014000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2140000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1550000 usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
11272000 usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
6557000 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
67000000 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
40000000 usd
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
75000000 usd
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
45000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13055000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9936000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1825000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2650000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7566000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3496000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5741000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6146000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
22125000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
14847000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Interest Paid Net
InterestPaidNet
3252000 usd
us-gaap Interest Paid Net
InterestPaidNet
3345000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2887000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3844000 usd
CY2023Q2 us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
7000000 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
3000000 usd
CY2023Q4 us-gaap Revenues
Revenues
208496000 usd
CY2023Q1 us-gaap Revenues
Revenues
219218000 usd
us-gaap Revenues
Revenues
696142000 usd
us-gaap Revenues
Revenues
706953000 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20781632 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20818347 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20864349 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20847285 shares
CY2023Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
125689 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
155917 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
139728 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
157564 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20907321 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20974264 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21004077 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21004849 shares
CY2023Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
24065 shares
CY2023Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1500000 usd
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
102657000 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
128589000 usd
CY2023Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
33852000 usd
CY2023Q2 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
39812000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
68805000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
88777000 usd
CY2023Q4 us-gaap Lifo Inventory Amount
LIFOInventoryAmount
78700000 usd
CY2023Q2 us-gaap Lifo Inventory Amount
LIFOInventoryAmount
101400000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
101500000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
77400000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
168835000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
53334000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
115501000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
119381000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
47548000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
71833000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1227000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1227000 usd
CY2023Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1227000 usd
CY2023Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1227000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
170062000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
53334000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
116728000 usd
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
120608000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
47548000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
73060000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
120000000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
112000000 usd
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
290000 usd
CY2023Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
356000 usd
CY2023Q4 hwkn Totaldebtnetofdebtissuancecosts
Totaldebtnetofdebtissuancecosts
119710000 usd
CY2023Q2 hwkn Totaldebtnetofdebtissuancecosts
Totaldebtnetofdebtissuancecosts
111644000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
9913000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
9913000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
109797000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
101731000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.25
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.26
CY2023Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
2600000 shares
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
11300000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
181657 shares
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
6600000 usd
CY2023Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
937487 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
us-gaap Description Of Basis Of Accounting For Transactions Between Reportable Segments
DescriptionOfBasisOfAccountingForTransactionsBetweenReportableSegments
no
hwkn Number Of Operating Segments Aggregated
NumberOfOperatingSegmentsAggregated
0 segment
us-gaap Segment Reporting Disclosure Of Major Customers
SegmentReportingDisclosureOfMajorCustomers
No
CY2023Q4 us-gaap Revenues
Revenues
208496000 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
42248000 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23774000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
18474000 usd
CY2023Q1 us-gaap Revenues
Revenues
219218000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
36271000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21004000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
15267000 usd
us-gaap Revenues
Revenues
696142000 usd
us-gaap Gross Profit
GrossProfit
148125000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
64173000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
83952000 usd
us-gaap Revenues
Revenues
706953000 usd
us-gaap Gross Profit
GrossProfit
129394000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
59727000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
69667000 usd
us-gaap Quarterly Financial Information Segment Reporting Segment Assets Material Change
QuarterlyFinancialInformationSegmentReportingSegmentAssetsMaterialChange
No

Files In Submission

Name View Source Status
hwkn-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0000046250-24-000004-index-headers.html Edgar Link pending
0000046250-24-000004-index.html Edgar Link pending
0000046250-24-000004.txt Edgar Link pending
0000046250-24-000004-xbrl.zip Edgar Link pending
a10qfy2024q3123123ex311.htm Edgar Link pending
a10qfy2024q3123123ex312.htm Edgar Link pending
a10qfy2024q3123123ex321.htm Edgar Link pending
a10qfy2024q3123123ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hwkn-20231231.htm Edgar Link pending
hwkn-20231231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
hwkn-20231231_cal.xml Edgar Link unprocessable
hwkn-20231231_def.xml Edgar Link unprocessable
hwkn-20231231_lab.xml Edgar Link unprocessable
hwkn-20231231_htm.xml Edgar Link completed
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending